PANCREATIC ADENOCARCINOMA METASTATIC
Clinical trials for PANCREATIC ADENOCARCINOMA METASTATIC explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC ADENOCARCINOMA METASTATIC trials appear
Sign up with your email to follow new studies for PANCREATIC ADENOCARCINOMA METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for pancreatic cancer patients in global drug trial
Disease control Recruiting nowThis study is testing whether a new drug called daraxonrasib, given alone or with standard chemotherapy, works better than chemotherapy alone for people with advanced pancreatic cancer that has spread. About 900 participants will be randomly assigned to receive one of three treat…
Matched conditions: PANCREATIC ADENOCARCINOMA METASTATIC
Phase: PHASE3 • Sponsor: Revolution Medicines, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Wearable device zaps pancreatic tumors in new trial
Disease control Recruiting nowThis study is testing whether a wearable device that delivers low-intensity electric fields (called TTFields) is safe and helpful when used alongside standard chemotherapy for advanced pancreatic cancer that has spread. It will involve about 30 adults to see if the combination ca…
Matched conditions: PANCREATIC ADENOCARCINOMA METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Clinica Universidad de Navarra, Universidad de Navarra • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New weapon tested in fight against tough pancreatic cancer
Disease control Recruiting nowThis early-stage trial is testing a new drug called OMTX705, given alongside standard chemotherapy and an immunotherapy drug, for people with advanced pancreatic cancer that has spread. The main goal is to find a safe dose and see how well the body tolerates the combination. Rese…
Matched conditions: PANCREATIC ADENOCARCINOMA METASTATIC
Phase: PHASE1 • Sponsor: Oncomatryx Biopharma S.L. • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Radical stem cell combo aims to outsmart tough cancers
Disease control Recruiting nowThis early-stage trial is testing a new treatment for people with metastatic pancreatic or breast cancer. The goal is to see if a combination of high-dose chemotherapy drugs, vitamins, and the patient's own stem cells is safe and can overcome the cancer's resistance to treatment.…
Matched conditions: PANCREATIC ADENOCARCINOMA METASTATIC
Phase: PHASE1 • Sponsor: General Oncology, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New drug duo aims to hold deadly pancreatic cancer at bay
Disease control Recruiting nowThis study is testing whether a combination of two drugs, niraparib and ipilimumab, can help keep metastatic pancreatic cancer from getting worse in people whose disease has stabilized after initial chemotherapy. It will compare this two-drug approach to standard chemotherapy. Th…
Matched conditions: PANCREATIC ADENOCARCINOMA METASTATIC
Phase: PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC